Pharmaceutical Industry

Page 37 of 100

COVID-19-Coronavirus-microscope
Health

The first U.S. trial for a coronavirus treatment has started

By
February 25, 2020
Japan taps an unexpected drugmaker for its coronavirus treatment
International

Japan taps an unexpected drugmaker for its coronavirus treatment

By
February 25, 2020
Antibiotics AI
Newsletters

How A.I. helps sniff out new antibiotics

By
February 25, 2020
AUSTRALIA-HEALTH-HOSPITAL-DISEASE-SUPERBUG
Health

Scientists are turning to A.I. to discover new antibiotics that can fight superbugs

By
February 25, 2020
Sanofi CEO Paul Hudson
Newsletters

Coronavirus interruption of drug supply chain pushes Sanofi to open a firm in France

By
February 24, 2020
2nd China International Import Expo (CIIE) - Day 2
Health

Sanofi is set to launch a new European drug manufacturing firm

By
February 24, 2020
China’s high smoking rate may be exacerbating the coronavirus outbreak
Health

China’s high smoking rate may be exacerbating the coronavirus outbreak

By
February 19, 2020
Coronavirus vaccine SARS lessons
Health

SARS treatments could help with the new coronavirus. Why were they shelved?

By
February 18, 2020
PSY.03.20.Tim Ferriss-featured image
Magazine

Business gets ready to trip: How psychedelic drugs may revolutionize mental health care

By
February 17, 2020
AstraZeneca coronavirus
Health

AstraZeneca stock slips on mixed earnings report and coronavirus uncertainty

By
February 14, 2020
INV.03.20.Immunotherapy-Drugs
Magazine

‘Miracle’ cancer treatments could be a blessing for investors too

By
February 13, 2020
generic drug shot gene therapy
Commentary

How this gene therapy drug earned its $2.1 million price tag

By
February 7, 2020
CRISPR Gene Editing Trial Cancer Safety
Newsletters

First step in study shows CRISPR gene-edited cells are safe for use in cancer patients

By
February 6, 2020
Workers protective suits prepare surgical masks at a factory in China during the Wuhan coronavirus outbreak.
Tech

Startup uses A.I. to identify molecules that could fight coronavirus

By
February 6, 2020
Nestle Aimmune Peanut Allergy Drug
Newsletters

Nestlé invests another $200 million in Aimmune’s peanut allergy drug

By
February 6, 2020

Most Popular